First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54%
Updated: Apr 29, 2024

Clarus Therapeutics Holdings Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Net Income (Common) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Net Income (Common)
-$40.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income (Common)
$40.6B
CAGR 3-Years
39%
CAGR 5-Years
23%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income (Common)
$8B
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Net Income (Common)
$2.1B
CAGR 3-Years
-40%
CAGR 5-Years
-28%
CAGR 10-Years
-21%
Merck & Co Inc
NYSE:MRK
Net Income (Common)
$365m
CAGR 3-Years
-63%
CAGR 5-Years
-43%
CAGR 10-Years
-22%
Eli Lilly and Co
NYSE:LLY
Net Income (Common)
$5.2B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
1%

See Also

What is Clarus Therapeutics Holdings Inc's Net Income (Common)?
Net Income (Common)
-40.6m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Net Income (Common) amounts to -40.6m USD.